Faculty Opinions recommendation of Phase I trial of a formulated IL-12 plasmid in combination with carboplatin and docetaxel chemotherapy in the treatment of platinum-sensitive recurrent ovarian cancer.

2013 ◽  
Author(s):  
Roberto Angioli
Keyword(s):  
Ovarian Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
Recurrent Ovarian Cancer ◽  
Platinum Sensitive ◽  
Docetaxel Chemotherapy

scholarly journals A Phase I Trial of Dasatinib, an Src-Family Kinase Inhibitor, in Combination with Paclitaxel and Carboplatin in Patients with Advanced or Recurrent Ovarian Cancer

2012 ◽  
Vol 18 (19) ◽  
pp. 5489-5498 ◽  
Author(s):  
Angeles Alvarez Secord ◽  
Deanna K. Teoh ◽  
William T. Barry ◽  
Miao Yu ◽  
Gloria Broadwater ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
Kinase Inhibitor ◽  
Recurrent Ovarian Cancer ◽  
Src Family Kinase

scholarly journals The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR

2006 ◽  
Vol 17 (10) ◽  
pp. 1568-1577 ◽  
Author(s):  
J. Pfisterer ◽  
A. du Bois ◽  
J. Sehouli ◽  
S. Loibl ◽  
S. Reinartz ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
Recurrent Ovarian Cancer ◽  
Idiotypic Antibody

A phase-I trial of a novel autologous oxidized whole-tumor antigen vaccine therapy for recurrent ovarian cancer

2013 ◽  
Vol 130 (1) ◽  
pp. e11-e12
Author(s):  
J. Tanyi ◽  
L. Kandalaft ◽  
C. Chiang ◽  
G. Mantia-Smaldone ◽  
E. Zsiros ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase I ◽  
Tumor Antigen ◽  
Phase I Trial ◽  
Recurrent Ovarian Cancer ◽  
Vaccine Therapy ◽  
Antigen Vaccine

Phase I trial of ribociclib (LEE-011) with platinum-based chemotherapy in recurrent platinum sensitive ovarian cancer

2021 ◽  
Vol 162 ◽  
pp. S69
Author(s):  
Lan Coffman ◽  
Taylor Orellana ◽  
Daniel Normolle ◽  
Madeleine Courtney-Brooks ◽  
Michelle Boisen ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
Platinum Sensitive ◽  
Platinum Based Chemotherapy

scholarly journals Pharmacokinetically guided phase I trial of topotecan and etoposide phosphate in recurrent ovarian cancer

2005 ◽  
Vol 93 (1) ◽  
pp. 60-69 ◽  
Author(s):  
N C Levitt ◽  
D J Propper ◽  
S Madhusudan ◽  
J P Braybrooke ◽  
C Echeta ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase I ◽  
Phase I Trial ◽  
Recurrent Ovarian Cancer ◽  
Etoposide Phosphate
Sign in / Sign up

Export Citation Format

Share Document